Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Biotalys
  6. News
  7. Summary
    BTLS   BE0974386188

BIOTALYS

(BTLS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Biotalys NV Reports Consolidated Earnings Results for the Six Months Ended June 30, 2021

09/17/2021 | 01:00am EST

Biotalys NV reported consolidated earnings results for the six months ended June 30, 2021. For the six months, the company reported Other operating income of €8.8 million compared to €0.6 million a year ago. Operating loss (EBIT) was of €8.4 million compared to €6.3 million a year ago. Loss for the period was of €7.2 million or €9.54 per Basic and diluted share compared to €5.3 million or €7.10 per Basic and diluted share a year ago.


© S&P Capital IQ 2021
All news about BIOTALYS
11/15Biotalys? First Biocontrol Evoca? Demonstrated to Be an Excellent New Tool for Growers ..
CI
09/30Biotalys Announces the Appointment of Patrick Mcdonnell as Chief Business Officer, Effe..
CI
09/17BIOTALYS' : Chief Scientific Officer Steps Down
MT
09/17Biotalys Announces Management Changes
CI
09/17Biotalys NV Reports Consolidated Earnings Results for the Six Months Ended June 30, 202..
CI
07/01Biotalys NV has completed an IPO in the amount of €47.499998 million.
CI
06/23BIOTALYS : Stock market flotation
CO
06/22Biotalys NV has filed an IPO in the amount of €61.908322 million.
CI
06/22BIOTALYS : Ipo
CO
06/10BIOTALYS : Nomination
CO
More news
Financials
Sales 2021 2,00 M 2,26 M 2,26 M
Net income 2021 -17,4 M -19,6 M -19,6 M
Net cash 2021 51,6 M 58,3 M 58,3 M
P/E ratio 2021 -12,0x
Yield 2021 -
Capitalization 217 M 244 M 246 M
EV / Sales 2021 82,9x
EV / Sales 2022 92,6x
Nbr of Employees 45
Free-Float 54,2%
Chart BIOTALYS
Duration : Period :
Biotalys Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOTALYS
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 7,06 €
Average target price 9,60 €
Spread / Average Target 36,0%
EPS Revisions
Managers and Directors
Patrice Sellès Chief Executive Officer & Director
Wim Ottevaere Chief Financial Officer
Simon E. Moroney Chairman
Marnix Peferoen Chief Technology Officer
Luc Maertens Chief Operating Officer & Director
Sector and Competitors
1st jan.Capi. (M$)
BIOTALYS0.00%247
MUYUAN FOODS CO., LTD.-11.08%42 595
CORTEVA, INC.21.64%34 332
GUANGDONG HAID GROUP CO., LIMITED5.47%17 682
WENS FOODSTUFF GROUP CO., LTD.-3.78%17 115
SITEONE LANDSCAPE SUPPLY, INC.53.67%10 499